BioNexus Gene Lab Corp Common stock (BGLC) had the highest return between 2014 and 2022 by a US stock in the Nasdaq Composite (IXIC), returning 2,780,387.8%.

ASSET	YEARS	% RETURN
BioNexus Gene Lab Corp Common stock (BGLC)	2014-2022	2,780,387.8%
LMF Acquisition Opportunities (ICU)	2014-2022	2,614,695.92%
Next Technology (NXTT)	2014-2022	1,162,346.87%
Connexa Sports Technologies (YYAI)	2014-2022	467,900%
GeoVax Labs (GOVX)	2014-2022	393,650%
Heart Test Laboratories Inc Common Stock (HSCS)	2014-2022	246,958.82%
AquaBounty Technologies (AQB)	2014-2022	212,122.22%
Immatics (IMTX)	2014-2022	174,100%
MDxHealth SA ADR (MDXH)	2014-2022	165,150%
Iqstel (IQST)	2014-2022	146,895.96%
INVO Fertility (IVF)	2014-2022	141,233.33%
Eastside Distilling (BLNE)	2014-2022	137,437.54%
Aurora Cannabis (ACB)	2014-2022	122,966.67%
SurgePays (SURG)	2014-2022	93,614.29%
Applied Digital (APLD)	2014-2022	73,500%
Blackboxstocks (BLBX)	2014-2022	70,488.24%
Helport AI Limited Ordinary Shares (HPAI)	2014-2022	67,300%
TCTM Kids IT Education (VSA)	2014-2022	30,555.11%
Celsius (CELH)	2014-2022	26,576.92%
Akari Therapeutics (AKTX)	2014-2022	26,378.87%
Guardforce AI (GFAI)	2014-2022	24,323.08%
FingerMotion (FNGR)	2014-2022	22,380%
Processa Pharmaceuticals (PCSA)	2014-2022	18,233.33%
LM Funding America (LMFA)	2014-2022	11,051.52%
Avalon GloboCare (ALBT)	2014-2022	11,042.86%